Rifampicin-associated segmental necrotizing glomerulonephritis in staphylococcal endocarditis

Area of Science:

• Nephrology
• Infectious Diseases
• Pharmacology

Background:

• Rifampicin is a key antibiotic for tuberculosis and increasingly used for Staphylococcal infections like infective endocarditis (IE).
• Segmental necrotising glomerulonephritis is a known, albeit rare, complication of rifampicin treatment.
• The evolving landscape of infectious diseases necessitates a re-evaluation of antibiotic-associated renal risks.

Observation:

• A patient with Staphylococcal IE developed acute renal failure.
• Renal biopsy revealed segmental necrotising glomerulonephritis.
• The patient was undergoing treatment with rifampicin for Staphylococcal IE.

Findings:

• The case illustrates a direct link between rifampicin therapy and the development of segmental necrotising glomerulonephritis.
• This adverse event resulted in significant acute kidney injury.
• Literature review confirms rifampicin-induced glomerulonephritis as a potential complication.

Implications:

• Clinicians should be vigilant for renal complications in patients treated with rifampicin, especially for Staphylococcal infections.
• Early recognition and management of rifampicin-induced glomerulonephritis are crucial to prevent irreversible kidney damage.
• This highlights the importance of monitoring renal function during rifampicin therapy for diverse infections.